IDEX Biometrics ASA
IDBA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.07 | 2.04 | -4.91 | 3.62 |
| FCF Yield | -2.43% | -1.94% | -0.52% | -0.55% |
| EV / EBITDA | -4.10 | -55.38 | -179.05 | -175.20 |
| Quality | ||||
| ROIC | -112.01% | -128.50% | -82.54% | -137.65% |
| Gross Margin | 5.58% | 20.72% | 55.85% | 74.89% |
| Cash Conversion Ratio | 1.01 | 0.98 | 0.85 | 0.87 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.50% | 55.18% | 161.79% | 63.54% |
| Free Cash Flow Growth | 15.02% | -16.51% | -16.84% | 16.97% |
| Safety | ||||
| Net Debt / EBITDA | 0.02 | 0.15 | 1.13 | 0.25 |
| Interest Coverage | -40.38 | -950.58 | -1,011.29 | -55.35 |
| Efficiency | ||||
| Inventory Turnover | 0.61 | 0.73 | 1.02 | 0.32 |
| Cash Conversion Cycle | 618.10 | 530.28 | 357.85 | 852.62 |